Imeke Goldschmidt
Overview
Explore the profile of Imeke Goldschmidt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
244
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chichelnitskiy E, Goldschmidt I, Ruhl L, Rubsamen N, Jaeger V, Karch A, et al.
J Hepatol
. 2024 May;
81(5):862-871.
PMID: 38821361
Background & Aims: After pediatric liver transplantation (pLT), children undergo life-long immunosuppression since reliable biomarkers for the assessment of rejection probability are scarce. In the multicenter (n = 7) prospective...
2.
Goldschmidt I, Chichelnitskiy E, Gotz J, Rubsamen N, Karch A, Jager V, et al.
Liver Transpl
. 2023 Sep;
30(3):288-301.
PMID: 37678230
Steroid-free immunosuppression protocols gained popularity in pediatric liver transplantation (pLT) after the introduction of IL-2-receptor blockade for induction therapy. We analyzed the clinical and immunologic outcome data of the multicenter...
3.
Pfister E, Jaeger V, Karch A, Shay D, Schukfeh N, Ohlendorf J, et al.
Hepatol Commun
. 2023 Mar;
7(4).
PMID: 36995996
Background: Bile salt export pump (ABCB11) deficiency [Progressive familial intrahepatic cholestasis (PFIC2)] is the most common genetic cause of PFIC and is associated with pruritus and progressive liver disease. Surgical...
4.
Ohlendorf J, Kiene H, Wiegandt J, Karch A, Jaeger V, Laue T, et al.
J Clin Med
. 2023 Mar;
12(6).
PMID: 36983111
Epidemiological evidence suggests that thrombophilic factors, including male sex, non-O blood type, MTHFRnt677TT mutation, factor V Leiden G1691A mutation, and prothrombin G20210A polymorphism, may contribute to the progression of fibrosis...
5.
Goldschmidt I, Chichelnitskiy E, Rubsamen N, Jaeger V, Karch A, DAntiga L, et al.
Children (Basel)
. 2023 Jan;
10(1).
PMID: 36670678
Background: The current gold standard to diagnose T-cell-mediated acute rejection (TCMR) requires liver histology. Using data from the ChilSFree study on immune response after paediatric liver transplantation (pLT), we aimed...
6.
Memaran N, Wilke H, Sugianto R, Baumann U, Bauer E, Swallow M, et al.
Liver Transpl
. 2022 Jun;
28(11):1766-1775.
PMID: 35666175
Leukocyte telomere length (LTL) is a marker for biological age. Pediatric liver transplant recipients show a high rate of subclinical atherosclerosis, indicated by elevated intima-media thickness (IMT). We hypothesized that...
7.
Ohlendorf J, Goldschmidt I, Junge N, Laue T, Nasser H, Jackel E, et al.
Children (Basel)
. 2022 May;
9(5).
PMID: 35626847
Familial intrahepatic cholestasis 1 (FIC1) disease is a genetic disorder characterized by hepatic and gastrointestinal disease due to deficiency, often requiring liver transplantation (LT). Extrahepatic symptoms, such as diarrhea, malabsorption,...
8.
Stasch L, Ohlendorf J, Baumann U, Ernst G, Lange K, Konietzny C, et al.
Children (Basel)
. 2022 Jan;
9(1).
PMID: 35053722
Objective: Structured education programs have been shown to improve somatic outcome and health-related quality of life (HRQOL) in a variety of chronic childhood diseases. Similar data are scarce in paediatric...
9.
Ohlendorf J, Stasch L, Baumann U, Konietzny C, Pfister E, Ernst G, et al.
Children (Basel)
. 2021 Sep;
8(9).
PMID: 34572259
In the absence of widely accepted education standards for parents of children after liver transplantation (LTx), the content and structure of parental training are influenced by health care practitioners' (HCP)...
10.
Leiskau C, Junge N, Pfister E, Goldschmidt I, Mutschler F, Laue T, et al.
Children (Basel)
. 2021 Aug;
8(8).
PMID: 34438532
(1) Background and Aim: Despite excellent long-term results in pediatric liver transplantation (pLTx), mortality and graft loss still are to be diminished. We aim to describe time-dependent changes and long-term...